Zentalis Pharmaceuticals, Inc. (ZNTL)
1.46
+0.10
(+7.35%)
USD |
NASDAQ |
Nov 20, 11:01
Zentalis Pharmaceuticals Free Cash Flow : -133.87M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -133.87M |
| June 30, 2026 | -128.13M |
| March 31, 2026 | -125.60M |
| December 31, 2025 | -125.25M |
| September 30, 2025 | -134.01M |
| June 30, 2025 | -151.09M |
| March 31, 2025 | -151.70M |
| December 31, 2024 | -171.08M |
| September 30, 2024 | -172.15M |
| June 30, 2024 | -166.86M |
| March 31, 2024 | -211.14M |
| December 31, 2023 | -208.40M |
| September 30, 2023 | -205.12M |
| June 30, 2023 | -201.22M |
| Date | Value |
|---|---|
| March 31, 2023 | -164.94M |
| December 31, 2022 | -166.30M |
| September 30, 2022 | -168.02M |
| June 30, 2022 | -169.31M |
| March 31, 2022 | -172.94M |
| December 31, 2021 | -160.20M |
| September 30, 2021 | -149.01M |
| June 30, 2021 | -133.46M |
| March 31, 2021 | -108.59M |
| December 31, 2020 | -87.58M |
| September 30, 2020 | -72.79M |
| June 30, 2020 | -62.28M |
| March 31, 2020 | -47.35M |
| December 31, 2019 | -39.50M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ARS Pharmaceuticals, Inc. | -183.07M |
| ACADIA Pharmaceuticals, Inc. | 81.99M |
| Alnylam Pharmaceuticals, Inc. | 752.13M |
| Anika Therapeutics, Inc. | 2.295M |
| Savara, Inc. | -130.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -32.71M |
| Cash from Investing (Quarterly) | -55.31M |
| Cash from Financing (Quarterly) | 87.26M |
| Free Cash Flow Per Share (Quarterly) | -0.3866 |
| Free Cash Flow to Equity (Quarterly) | -31.72M |
| Free Cash Flow to Firm (Quarterly) | -32.71M |
| Free Cash Flow Yield | -93.32% |